Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Immunisation, Pustule, Rash erythematous, Rash papular, Rash pruritic
Clinical narrative: Administration date 03Oct2021, dose number=3; Developed an itchy, red rash with open pustules and hard bumpy skin on the underside of my forearm; Developed an itchy, red rash with open pustules and hard bumpy skin on the underside of my forearm; Developed an itchy, red rash with open pustules and hard bumpy skin on the underside of my forearm; Developed an itchy, red rash with open pustules and hard bumpy skin on the underside of my forearm; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FR8730) in the left arm on 27Mar2021 (at the age of 59-years-old) and also received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2588) in the left arm on 03Oct2021 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension on an unknown date, renal cell carcinoma since on an unknown date in 2019 and radical nephrectomy on an unknown date in 2019. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included amlodipine (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) in the left arm on 06Mar2021 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. On 06Apr2021, approximately 10 days after second vaccine and on 15Oct2021, at 07:00, approximately 10 days after the third vaccine (booster), the patient developed an itchy, red rash with open pustules and hard bumpy skin on the underside of her forearm. The patient was currently still experiencing this rash and she had 2 new pustules on her left calf now (at the time of this report). The reaction, after vaccine number 2 lasted about 3-4 weeks. On 03Oct2021, the patient had "administration date 03Oct2021, dose number=3". The events developed an itchy, red rash with open pustules and hard bumpy skin on the underside of her forearm resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events developed itchy, red rash with open pustules and hard bumpy skin on the underside of her forearm and included treatment with cortisone (MANUFACTURER UNKNOWN) cream. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events developed itchy, red rash with open pustules and hard bumpy skin on the underside of her forearm (onset date: 06Apr2021) was resolved on an unknown date in 2021. The clinical outcome of the events developed itchy, red rash with open pustules and hard bumpy skin on the underside of her forearm (onset date: 15Oct2021 at 07:00) was not resolved at the time of this report. The clinical outcome of the event "administration date 03Oct2021, dose number=3" was unknown at the time of this report.